Literature DB >> 23815287

Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.

B Zöller1, X Li, J Sundquist, K Sundquist.   

Abstract

OBJECTIVES: Socio-economic and occupational factors may contribute to risk of immune-mediated disorders. The importance of these factors in giant cell arteritis (GCA) is unknown. This is the first nationwide study with the aim of investigating possible associations between socio-economic status (SES)/occupation and hospitalization for GCA.
METHOD: A nationwide database was constructed by linking Swedish census data to the Hospital Discharge Register to obtain data on all first hospitalizations with a main diagnosis of GCA in Swedish adults between 1970 and 2008. Standardized incidence ratios (SIRs) and 95% confidence intervals were calculated for different occupations. Three cohorts were defined based on 53 occupational titles recorded in Swedish census data in 1970, 1980, and 1990.
RESULTS: In individuals aged over 50 years, 3293 males and 4726 females were hospitalized with GCA. Only minor or inconsistent associations were observed for education and SES and GCA. Some occupations were associated with increased risk of GCA. However, the risks were modest or not consistent between the three cohorts investigated. Only male fishermen, whalers, and sealers had an SIR of > 2 (2.14). However, the risk of GCA was only increased in one cohort. Both women (0.83) and men (0.83) born outside Sweden had a lower risk of GCA. The adjustment variables hypertension, diabetes, chronic obstructive pulmonary disease (COPD), and coronary heart disease (CHD) were associated with higher risk of GCA.
CONCLUSIONS: Occupation and SES are not strong risk factors for GCA. However, GCA was associated with co-morbidities and country of birth, calling for further studies.

Entities:  

Mesh:

Year:  2013        PMID: 23815287     DOI: 10.3109/03009742.2013.793777

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  6 in total

Review 1.  Clinical practice. Giant-cell arteritis and polymyalgia rheumatica.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 91.245

2.  MDS and GCA: a prognostic dilemma.

Authors:  Neha G Narula; Andy Abril
Journal:  Clin Rheumatol       Date:  2015-06-18       Impact factor: 2.980

3.  Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.

Authors:  Cristian Labarca; Matthew J Koster; Cynthia S Crowson; Ashima Makol; Steven R Ytterberg; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2015-09-18       Impact factor: 7.580

4.  Body mass index and the risk of giant cell arteritis: results from a prospective study.

Authors:  Karin Jakobsson; Lennart Jacobsson; Kenneth Warrington; Eric L Matteson; Kimberly Liang; Olle Melander; Carl Turesson
Journal:  Rheumatology (Oxford)       Date:  2014-09-05       Impact factor: 7.580

5.  Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in Australia and New Zealand: is there a seasonal influence?

Authors:  Elisabeth De Smit; Linda Clarke; Paul G Sanfilippo; Tony R Merriman; Matthew A Brown; Catherine L Hill; Alex W Hewitt
Journal:  RMD Open       Date:  2017-08-29

6.  Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements.

Authors:  Rosanna Dammacco; Giovanni Alessio; Ermete Giancipoli; Patrizia Leone; Anna Cirulli; Leonardo Resta; Angelo Vacca; Franco Dammacco
Journal:  Clin Ophthalmol       Date:  2020-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.